SYS-CON MEDIA Authors: Newswire, David Smith, Tim Crawford, Kevin Benedict, Gilad Parann-Nissany

News Feed Item

ResearchDx, the Leading Contract Diagnostics Organization, Receives a Strategic Partner Award From WuXi AppTec

ResearchDx, LLC of Irvine, California announced today that it has received a 2013 Strategic Partner Award from WuXi AppTec, Ltd. The award was given in recognition of the outstanding consulting and personnel services provided to the WuXi AppTec Genome Center Clinical Laboratory in attaining Clinical Laboratory Improvement Amendments (CLIA) certification from the Centers for Medicare and Medicaid Services of the U.S. Department of Health and Human Services. WuXi’s clinical laboratory is the only CLIA-certified clinical laboratory in China.

“We are delighted to receive the Strategic Partner Award from WuXi AppTec, a global pharmaceutical, biopharmaceutical, and medical device R&D services company, and are proud to partner with them. Our mutual success is based on a shared commitment to provide services of the highest quality to clinical laboratory clients,” said Dr. Philip Cotter, Principal and Co-Founder of ResearchDx.

The Consulting Services Division of ResearchDx provides comprehensive Clinical Laboratory consulting services encompassing quality management systems; assay design, validation and implementation; and consulting for CLIA and International CLIA certification, State licensures, and Joint Commission International, College of American Pathologists, and ISO 15189 accreditations.

“The award is timely, as ResearchDx is increasingly working with international clients seeking accreditations for their Clinical Laboratories. ResearchDx offers its clients unparalleled experience in opening, licensing, and operating Clinical Laboratories, both in the U.S. and overseas,” said Dr. Mathew Moore, Principal and Co-Founder of ResearchDx.

ResearchDx is the leading Contract Diagnostics Organization serving the biopharmaceutical and diagnostic industries. The company provides comprehensive, integrated, and flexible services for the in vitro diagnostic development process. From initial assay conceptualization, discovery, optimization, and validation in a CAP/CLIA laboratory environment through a complete set of clinical research services and regulatory approval, ResearchDx offers solutions to meet customers’ complex needs in diagnostics development. ResearchDx’s primary service areas include assay research and development, clinical laboratory services, clinical research, diagnostic manufacturing, and consulting. Additional information is available at

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.